Education
About Us
Working with TipRanks
Follow Us
Cormedix (CRMD)
NASDAQ:CRMD
Total Valuation
Cormedix has a market cap or net worth of $450.41M. The enterprise value is $447.05M.
Market Cap$450.41M
Enterprise Value$447.05M
Share Statistics
Cormedix has 65.18M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding65.18M
Owned by Insiders2.34%
Owned by Instutions9.92%
Financial Efficiency
Cormedix’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -0.02%.
Return on Equity (ROE)-0.02%
Return on Assets (ROA)-0.02%
Return on Invested Capital (ROIC)-0.02%
Return on Capital Employed (ROCE)-0.03%
Revenue Per Employee$679,252.656
Profits Per Employee-$280,156.563
Employee Count64
Asset Turnover<0.01
Inventory Turnover<0.01
Valuation Ratios
The current PE Ratio of Cormedix is -26.60. Cormedix’s PEG ratio is >-0.01.
PE Ratio-26.60
PS Ratio10.97
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio>-0.01
Income Statement
In the last 12 months, Cormedix had revenue of $43.47M and earned -$17.93M in profits. Earnings per share was -$0.33.
Revenue$43.47M
Gross Profit$40.28M
Operating Income-$22.36M
Pretax Income-$19.32M
Net Income-$17.93M
EBITDA-18.87M
Earnings Per Share (EPS)-0.33
Cash Flow
In the last 12 months, operating cash flow was -$50.61M and capital expenditures -$115.73K, giving a free cash flow of -$50.73M billion.
Operating Cash Flow-$50.61M
Free Cash Flow-$50.73M
Free Cash Flow per Share-$0.78
Dividends & Yields
Cormedix pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-10614.16%
Earnings Yield-3.76%
Stock Price Statistics
Beta1.81
52-Week Price Change28.44%
50-Day Moving Average9.34
200-Day Moving Average8.39
Relative Strength Index (RSI)38.27
Average Volume (3m)1.89M
Important Dates
Cormedix upcoming earnings date is May 8, 2025, TBA.
Last Earnings DateMar 25, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Cormedix as a current ratio of 3.39, with Debt / Equity ratio of <0.01
Current Ratio3.39
Quick Ratio3.16
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio-614.10
Taxes
In the past 12 months, Cormedix has paid -$1.39M in taxes.
Income Tax-$1.39M
Effective Tax Rate7.22%
Enterprise Valuation
Cormedix EV to EBITDA ratio is -0.02, with an EV/FCF ratio of >-0.01.
EV to Sales10.05
EV to EBITDA-0.02
EV to Free Cash Flow>-0.01
EV to Operating Cash Flow>-0.01
Balance Sheet
Cormedix has $51.69M in cash and marketable securities with $517.01K in debt, giving a net cash position of -$51.17M billion.
Cash & Marketable Securities$51.69M
Total Debt$517.01K
Net Cash-$51.17M
Net Cash Per Share-$0.79
Tangible Book Value Per Share$1.41K
Margins
Gross margin is 92.66%, with operating margin of -51.43%, and net profit margin of -41.24%.
Gross Margin92.66%
Operating Margin-51.43%
Pretax Margin-44453.24%
Net Profit Margin-41.24%
EBITDA Margin-51426.90%
EBIT Margin-44.37%
Analyst Forecast
The average price target for Cormedix is $15.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$15.75
Price Target Upside127.93%
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast
EPS Growth Forecast64.53%